RAC 4.05% $1.54 race oncology ltd

$7 billion per annum revenue with only a 3% penetration into the...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 2,750 Posts.
    lightbulb Created with Sketch. 670
    $7 billion per annum revenue with only a 3% penetration into the market. And thats with a 50% reduction on the 7bill yearly revenue due to triangles conservative physician adoption rate. The numbers are so large as T said.

    Strong finish to your presentation Dr T@RaceOncology. Nice work. Could I ask why you use only a 3% market penetration? Seems quite conservative. Id imagine, using Bis, if successful would become SoC an be greater than 3%. I guess the figures are already ludicrous with 3% penetration and 50% skimmed off because it adds too many zeros to the BO figure.

    https://hotcopper.com.au/data/attachments/6349/6349207-1f821389f2c4186f22799f11b05384a7.jpg
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.